Monica A. McArthur, Ph.D.
Affiliations: | 2006 | University of Texas Medical Branch, Galveston, TX |
Area:
Pathology, Microbiology BiologyGoogle:
"Monica McArthur"Parents
Sign in to add mentor| Alan D. T. Barrett | grad student | 2006 | UTMB | |
| (Molecular determinants of viscerotropic yellow fever virus infection in the hamster model.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McArthur MA, Bchir S, Dubois E, et al. (2023) "Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials". Human Vaccines & Immunotherapeutics. 19: 2272535 |
| Rapaka RR, Cross AS, McArthur MA. (2021) Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines. Vaccines. 9 |
| McArthur MA, Zhang SL, Li L, et al. (2019) Molecular Characterization of Hamster-Adapted Yellow Fever Virus. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.) |
| Mani S, Toapanta FR, McArthur MA, et al. (2019) Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine |
| Rudolph ME, McArthur MA, Magder LS, et al. (2019) Characteristics of regulatory T-cell populations before and after Ty21a typhoid vaccination in children and adults. Clinical Immunology (Orlando, Fla.) |
| Rudolph ME, McArthur MA, Magder LS, et al. (2019) Diversity of Salmonella Typhi-responsive CD4 and CD8 T cells before and after Ty21a typhoid vaccination in children and adults. International Immunology |
| Rudolph ME, McArthur MA, Magder LS, et al. (2019) Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Typhi Antigen Presentation. Frontiers in Immunology. 10: 257 |
| Gaudinski MR, Houser KV, Morabito KM, et al. (2017) Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet (London, England) |
| McArthur MA. (2017) Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics. Viruses. 9 |
| McArthur MA, Maciel M, Pasetti MF. (2017) Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward. Vaccine |